{"id":"https://openalex.org/W3035489244","doi":"https://doi.org/10.2337/db20-233-or","title":"233-OR: Ultra-Rapid Lispro (URLi) Demonstrates Similar Time-in-Target Range to Humalog with the Medtronic MiniMed 670G Hybrid Closed-Loop System","display_name":"233-OR: Ultra-Rapid Lispro (URLi) Demonstrates Similar Time-in-Target Range to Humalog with the Medtronic MiniMed 670G Hybrid Closed-Loop System","publication_year":2020,"publication_date":"2020-06-01","ids":{"openalex":"https://openalex.org/W3035489244","doi":"https://doi.org/10.2337/db20-233-or","mag":"3035489244"},"language":"en","primary_location":{"id":"doi:10.2337/db20-233-or","doi":"https://doi.org/10.2337/db20-233-or","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db20-233-or","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005036709","display_name":"Bruce W. Bode","orcid":"https://orcid.org/0000-0002-9998-055X","observed_orcids":["https://orcid.org/0000-0002-9998-055X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"BRUCE W. BODE","raw_affiliation_strings":["Atlanta, GA, Minneapolis, MN, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta, GA, Minneapolis, MN, Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007119846","display_name":"Anders L. Carlson","orcid":"https://orcid.org/0000-0002-5738-2818","observed_orcids":["https://orcid.org/0000-0002-5738-2818"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ANDERS L. CARLSON","raw_affiliation_strings":["Atlanta, GA, Minneapolis, MN, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta, GA, Minneapolis, MN, Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"RONG LIU","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RONG LIU","raw_affiliation_strings":["Atlanta, GA, Minneapolis, MN, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta, GA, Minneapolis, MN, Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103638376","display_name":"Thomas Andrew Hardy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"THOMAS HARDY","raw_affiliation_strings":["Atlanta, GA, Minneapolis, MN, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta, GA, Minneapolis, MN, Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043896655","display_name":"Jennifer Boyd","orcid":"https://orcid.org/0000-0001-6123-8862","observed_orcids":["https://orcid.org/0000-0001-6123-8862"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JENNIFER BOYD","raw_affiliation_strings":["Atlanta, GA, Minneapolis, MN, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta, GA, Minneapolis, MN, Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034096266","display_name":"Richard M. Bergenstal","orcid":"https://orcid.org/0000-0002-9050-5584","observed_orcids":["https://orcid.org/0000-0002-9050-5584"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RICHARD M. BERGENSTAL","raw_affiliation_strings":["Atlanta, GA, Minneapolis, MN, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta, GA, Minneapolis, MN, Indianapolis, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012222593","display_name":"Scott Morrett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SCOTT MORRETT","raw_affiliation_strings":["Atlanta, GA, Minneapolis, MN, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta, GA, Minneapolis, MN, Indianapolis, IN","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021245924","display_name":"Debra A. Ignaut","orcid":"https://orcid.org/0000-0002-0449-9393","observed_orcids":["https://orcid.org/0000-0002-0449-9393"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DEBRA A. IGNAUT","raw_affiliation_strings":["Atlanta, GA, Minneapolis, MN, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlanta, GA, Minneapolis, MN, Indianapolis, IN","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9457,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.7529311,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"69","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-lispro","display_name":"insulin lispro","score":0.9330000281333923},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.828000009059906},{"id":"https://openalex.org/keywords/hybrid-closed-loop-system","display_name":"hybrid closed-loop system","score":0.8889999985694885},{"id":"https://openalex.org/keywords/minimed-670g","display_name":"MiniMed 670G","score":0.9470000267028809},{"id":"https://openalex.org/keywords/continuous-subcutaneous-insulin-infusion","display_name":"insulin pump therapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/time-in-range","display_name":"time in range","score":0.7210000157356262},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9269999861717224},{"id":"https://openalex.org/keywords/bolus-timing","display_name":"bolus timing","score":0.6129999756813049},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8460000157356262}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7924619913101196},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5924391150474548},{"id":"https://openalex.org/C2776486108","wikidata":"https://www.wikidata.org/wiki/Q3492616","display_name":"Insulin lispro","level":4,"score":0.5643076300621033},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.469509094953537},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.43141692876815796},{"id":"https://openalex.org/C2779794567","wikidata":"https://www.wikidata.org/wiki/Q941674","display_name":"Insulin pump","level":4,"score":0.4246622323989868},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.36599472165107727},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2454673945903778},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.23317477107048035},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2295583188533783},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.09706974029541016},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.06829386949539185},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db20-233-or","doi":"https://doi.org/10.2337/db20-233-or","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db20-233-or","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.5799999833106995,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3182339442","https://openalex.org/W3041794527","https://openalex.org/W7158001504","https://openalex.org/W3035136981","https://openalex.org/W3204779064","https://openalex.org/W2915883495","https://openalex.org/W2948999433","https://openalex.org/W4413138496","https://openalex.org/W3034473035","https://openalex.org/W3035149598"],"abstract_inverted_index":{"URLi":[0,30,52,81,152,185],"is":[1],"a":[2,38,85,191],"novel":[3],"ultra":[4],"rapid":[5],"formulation":[6],"of":[7,60,105,143,177],"insulin":[8,22],"lispro":[9],"that":[10],"shows":[11],"improved":[12],"postprandial":[13],"glucose":[14,63],"control":[15,122,189],"and":[16,132,158,190,221,241,298,315,321,330,372,380,386,391],"similar":[17,149,163,182,192],"compatibility":[18],"with":[19,55,62,80,92,110,123,197,204],"continuous":[20],"subcutaneous":[21],"infusion":[23],"(CSII)":[24],"vs.":[25],"Humalog.":[26,83],"In":[27],"this":[28],"study":[29,74],"was":[31,49,148,181],"evaluated":[32],"for":[33,138],"the":[34,43,58,106,198],"first":[35],"time":[36,61,130,144],"in":[37,145,202],"hybrid":[39],"closed-loop":[40],"system":[41,201],"using":[42,96],"Medtronic":[44],"MiniMed":[45,98,199],"670G.":[46],"Primary":[47],"objective":[48],"to":[50,53,57,103,195],"compare":[51],"Humalog":[54,154,196],"respect":[56],"percentage":[59,142],"values":[64],"within":[65],"target":[66],"range":[67,134],"70-180":[68],"mg/dL":[69],"(%TIR).":[70],"This":[71],"double-blind,":[72],"crossover":[73],"included":[75],"two":[76],"4-week":[77],"treatment":[78,108],"periods":[79],"or":[82,172],"After":[84],"2-week":[86],"lead-in":[87],"on":[88],"Humalog,":[89],"42":[90],"adults":[91],"type":[93,205],"1":[94,104,206],"diabetes":[95],"personal":[97],"670G":[99,200],"pumps":[100],"were":[101,161,167],"randomized":[102],"2":[107],"sequences":[109],"boluses":[111],"initiated":[112],"0-2":[113],"minutes":[114],"before":[115],"meals.":[116],"Both":[117],"treatments":[118],"achieved":[119],"good":[120],"glycemic":[121,188],"mean":[124],"TIR":[125],">75%":[126],"(Fig":[127],"1).":[128],"Mean":[129],"above":[131],"below":[133],"met":[135],"consensus":[136],"recommendations":[137],"both":[139],"treatments.":[140,165,184],"The":[141],"Auto":[146],"Mode":[147],"between":[150,164,183],"treatments:":[151],"92.0%;":[153],"91.4%.":[155],"Insulin":[156],"doses":[157],"pump":[159],"settings":[160],"generally":[162],"There":[166],"no":[168],"serious":[169],"adverse":[170,179],"events":[171,180],"early":[173],"discontinuations.":[174],"Overall":[175],"incidence":[176],"treatment-emergent":[178],"demonstrated":[186],"comparable":[187],"safety":[193],"profile":[194],"patients":[203],"diabetes.":[207],"Disclosure":[208],"B.W.":[209],"Bode:":[210],"Advisory":[211],"Panel;":[212],"Self;":[213,217,233,260,283,288,292,312,327,338,347,369,377,383],"InPen,":[214,266],"Medtronic.":[215,289],"Consultant;":[216,287,337],"ADOCIA,":[218],"Eli":[219,239,296,313,319,328,370,378,384,389],"Lilly":[220,240,297,314,320,329,352,371,379,385,390],"Company,":[222,242,299],"Lexicon":[223],"Pharmaceuticals,":[224,237,246,256,264,268,280],"Inc.,":[225,235,238,253,265,269,295,350],"Novo":[226,248,273,303,355],"Nordisk":[227,249,274,304,356],"A/S,":[228,250,275,305,357],"Pfizer":[229],"Inc.":[230,257,281],"Research":[231,290],"Support;":[232,291],"Dexcom,":[234,294,349],"Diasome":[236],"Gan":[243],"&":[244,343],"Lee":[245],"Medtronic,":[247,272,302,354],"Provention":[251],"Bio,":[252],"Senseonics,":[254,278],"Xeris":[255,279],"Speaker\u2019s":[258],"Bureau;":[259],"AstraZeneca,":[261],"Boehringer":[262],"Ingelheim":[263],"Janssen":[267],"MannKind":[270],"Corporation,":[271,301],"Sanofi,":[276,277,306,362],"Stock/Shareholder;":[282,382],"Glytec.":[284],"A.L.":[285],"Carlson:":[286],"Abbott,":[293,348],"Insulet":[300],"UnitedHealth":[307,363],"Group.":[308,364],"R.":[309],"Liu:":[310],"Employee;":[311,317,376],"Company.":[316,322,331,373,381,387],"Spouse/Partner;":[318],"T.":[323],"Hardy:":[324],"Other":[325,345,367],"Relationship;":[326,346,368],"J.":[332],"Boyd:":[333],"None.":[334],"R.M.":[335],"Bergenstal:":[336],"Ascensia":[339],"Diabetes":[340,360],"Care,":[341,361],"Johnson":[342],"Johnson.":[344],"Hygieia,":[351],"Diabetes,":[353],"Onduo,":[358],"Roche":[359],"S.":[365],"Morrett:":[366],"D.A.":[374],"Ignaut:":[375],"Funding":[388],"Company":[392]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":5}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2020-06-19T00:00:00"}